These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 153868)
1. Immune responses of diabetic animals. Direct immunosuppressant effects of streptozotocin in mice. Nichols WK; Spellman JB; Vann LL; Daynes RA Diabetologia; 1979 Jan; 16(1):51-7. PubMed ID: 153868 [No Abstract] [Full Text] [Related]
2. Endangered Lymphocytes: The Effects of Alloxan and Streptozotocin on Immune Cells in Type 1 Induced Diabetes. Queiroz LAD; Assis JB; Guimarães JPT; Sousa ESA; Milhomem AC; Sunahara KKS; Sá-Nunes A; Martins JO Mediators Inflamm; 2021; 2021():9940009. PubMed ID: 34712101 [TBL] [Abstract][Full Text] [Related]
3. Induction of tolerance to autoimmune diabetes with islet antigens. Herold KC; Montag AG; Buckingham F J Exp Med; 1992 Oct; 176(4):1107-14. PubMed ID: 1402656 [TBL] [Abstract][Full Text] [Related]
4. Camel whey protein improves oxidative stress and histopathological alterations in lymphoid organs through Bcl-XL/Bax expression in a streptozotocin-induced type 1 diabetic mouse model. Sayed LH; Badr G; Omar HM; Abd El-Rahim AM; Mahmoud MH Biomed Pharmacother; 2017 Apr; 88():542-552. PubMed ID: 28129627 [TBL] [Abstract][Full Text] [Related]
5. Chromium, selenium, and zinc multimineral enriched yeast supplementation ameliorates diabetes symptom in streptozocin-induced mice. Liu J; Bao W; Jiang M; Zhang Y; Zhang X; Liu L Biol Trace Elem Res; 2012 May; 146(2):236-45. PubMed ID: 22081404 [TBL] [Abstract][Full Text] [Related]
6. Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes. Paik SG; Fleischer N; Shin SI Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6129-33. PubMed ID: 6449703 [TBL] [Abstract][Full Text] [Related]
7. Immunologic features of mice with streptozotocin-induced diabetes: depression of their immune responses to sheep red blood cells. Ishibashi T; Kitahara Y; Harada Y; Harada S; Takamoto M; Ishibashi T Diabetes; 1980 Jul; 29(7):516-23. PubMed ID: 7380115 [TBL] [Abstract][Full Text] [Related]
8. Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice. Gaulton GN; Schwartz JL; Eardley DD Diabetologia; 1985 Oct; 28(10):769-75. PubMed ID: 2933286 [TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus in the rat: diminution in the number of cells in the thymus and of lymphocytes in the blood. Warley A; Daniel PM; Guthrie DL Q J Exp Physiol; 1987 Oct; 72(4):609-15. PubMed ID: 3501131 [TBL] [Abstract][Full Text] [Related]
10. Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line. McEvoy RC; Andersson J; Sandler S; Hellerström C J Clin Invest; 1984 Sep; 74(3):715-22. PubMed ID: 6088584 [TBL] [Abstract][Full Text] [Related]
11. Diabetes susceptibility of BALB/cBOM mice treated with streptozotocin. Inhibition by lethal irradiation and restoration by splenic lymphocytes. Paik SG; Blue ML; Fleischer N; Shin S Diabetes; 1982 Sep; 31(9):808-15. PubMed ID: 6219023 [TBL] [Abstract][Full Text] [Related]
12. Is the diabetogenic effect of streptozotocin in part thymus-dependent? Buschard K; Rygaard J Acta Pathol Microbiol Scand C; 1978 Feb; 86(1):23-7. PubMed ID: 152048 [TBL] [Abstract][Full Text] [Related]
13. Further study on the maturational impairment of thymic lymphocytes in streptozotocin-induced diabetic rats--from the view of peripheral lymphoid organs. Kinoshita Y; Tabata T; Kimura S; Toyokawa T; Okuno Y; Fujii S; Morii H Cell Mol Biol; 1987; 33(3):387-95. PubMed ID: 3496967 [No Abstract] [Full Text] [Related]
15. Response of thymus lymphocytes to streptozotocin-induced diabetes and exogenous vitamin C administration in rats. Ozerkan D; Ozsoy N; Cebesoy S Microscopy (Oxf); 2014 Dec; 63(6):409-17. PubMed ID: 25145646 [TBL] [Abstract][Full Text] [Related]
16. The role of thymic immunity and insulitis in the development of streptozocin-induced diabetes in mice. Nakamura M; Nagafuchi S; Yamaguchi K; Takaki R Diabetes; 1984 Sep; 33(9):894-900. PubMed ID: 6236118 [TBL] [Abstract][Full Text] [Related]
17. Protection against streptozotocin-induced diabetes by superoxide dismutase. Robbins MJ; Sharp RA; Slonim AE; Burr IM Diabetologia; 1980 Jan; 18(1):55-8. PubMed ID: 6444904 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of in vitro lymphocyte response by streptozotocin-induced diabetic rat serum. A function of very-low-density lipoproteins. Chi DS; Berry DL; Dillon KA; Arbogast BW Diabetes; 1982 Dec; 31(12):1098-1104. PubMed ID: 6217099 [No Abstract] [Full Text] [Related]
19. Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats. Tunali S; Yanardag R Pharmacol Res; 2006 Mar; 53(3):271-7. PubMed ID: 16431126 [TBL] [Abstract][Full Text] [Related]
20. Chemically-initiated hyperglycemia: streptozotocin-specific T lymphocyte reactions. Gleichmann H; Klinkhammer C Adv Exp Med Biol; 1988; 246():93-100. PubMed ID: 2977931 [No Abstract] [Full Text] [Related] [Next] [New Search]